Piedmont Capital Management (Montana)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Sell
2,678
-9
-0.3% -$3.08K 0.49% 30
2026
Q1
$923K Sell
2,687
-1
-0% -$356 0.47% 29
2025
Q4
$880K Buy
2,688
+1
+0% +$317 0.45% 29
2025
Q3
$801K Buy
2,687
+65
+2% +$18.9K 0.42% 31
2025
Q2
$732K Buy
2,622
+55
+2% +$15.6K 0.42% 31
2025
Q1
$719K Sell
2,567
-19
-0.7% -$5.61K 0.52% 27
2024
Q4
$671K Sell
2,586
-38
-1% -$11.3K 0.4% 30
2024
Q3
$845K Sell
2,624
-165
-6% -$54K 0.51% 27
2024
Q2
$768K Hold
2,789
0.52% 26
2024
Q1
$768K Buy
2,789
+60
+2% +$17.6K 0.52% 26
2023
Q4
$786K Sell
2,729
-69
-2% -$18.8K 0.57% 28
2023
Q3
$752K Buy
2,798
+45
+2% +$11.2K 0.6% 26
2023
Q2
$611K Buy
2,753
+66
+2% +$15.3K 0.46% 30
2023
Q1
$645K Buy
2,687
+124
+5% +$30.4K 0.52% 29
2022
Q4
$673K Sell
2,563
-41
-2% -$11K 0.56% 26
2022
Q3
$591K Buy
2,604
+70
+3% +$17K 0.53% 23
2022
Q2
$617K Sell
2,534
-79
-3% -$19.4K 0.63% 26
2022
Q1
$636K Buy
2,613
+671
+35% +$154K 0.48% 29
2021
Q4
$437K Buy
1,942
+58
+3% +$12.2K 0.34% 32
2021
Q3
$401K Buy
1,884
+456
+32% +$105K 0.32% 34
2021
Q2
$351K Buy
+1,428
New +$351K 0.29% 33

Other funds holding AMGN

Piedmont Capital Management (Montana)'s AMGN Position: Q2 2026 in Review

Piedmont Capital Management (Montana) reduced its Amgen (AMGN) stake by 0.33% in Q2 2026, selling an estimated $3.08K and leaving 2,678 shares worth $965K. The position accounts for 0.49% of the portfolio, ranked #30.

Piedmont Capital Management (Montana) first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Piedmont Capital Management (Montana) held 2,678 shares of Amgen worth $965K as of Q2 2026.
  • Piedmont Capital Management (Montana) sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
  • Amgen made up 0.49% of Piedmont Capital Management (Montana)'s portfolio in Q2 2026, its #30 holding.
  • Piedmont Capital Management (Montana) first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Piedmont Capital Management (Montana)'s 13F filing for Q2 2026, filed 13 Aug 2026.